Procoagulant molecular decoy for treating hemophilia A or B with or without inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9493761
APP PUB NO 20140050716A1
SERIAL NO

14002253

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a pharmaceutical composition including a modified factor Xa (GDXa), said modified GDXa being nonthrombogenic, able to bind to TFPI but not able to bind to phospholipids, for preventing or treating a hemorrhagic accident in a patient with hemophilia A or B with or without inhibitor.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE GRENOBLE ALPES38400 SAINT-MARTIN-D'HÈRES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Polack, Benoit Saint Martin le Vinoux, FR 4 36
Thomas, Aline Meylan, FR 4 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • A61K Class
  • 0 % this patent is cited more than
  • 9 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges6209860894426710349291291182201 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0500100015002000250030003500400045005000550060006500700075008000850090009500

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 15, 2028